XSPRAY.ST
XSpray Pharma AB (publ)
Price:  
45.30 
SEK
Volume:  
32,946.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XSPRAY.ST WACC - Weighted Average Cost of Capital

The WACC of XSpray Pharma AB (publ) (XSPRAY.ST) is 5.9%.

The Cost of Equity of XSpray Pharma AB (publ) (XSPRAY.ST) is 6.00%.
The Cost of Debt of XSpray Pharma AB (publ) (XSPRAY.ST) is 5.00%.

Range Selected
Cost of equity 4.20% - 7.80% 6.00%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.2% - 7.7% 5.9%
WACC

XSPRAY.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.33 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.20% 7.80%
Tax rate 20.60% 20.90%
Debt/Equity ratio 0.02 0.02
Cost of debt 5.00% 5.00%
After-tax WACC 4.2% 7.7%
Selected WACC 5.9%